refdb reference list

ID*:761 (2006)

Copelan,Edward A.

Hematopoietic stem-cell transplantation

N.Engl.J.Med. 354(17):1813-26


KEYWORDS: Transplantation, Homologous; Transplantation, Autologous; Transplantation Immunology; Transplantation Conditioning [methods]; Major Histocompatibility Complex; Humans; Hematopoietic Stem Cell Transplantation [adverse effects]; Graft vs Host Disease; Cord Blood Stem Cell Transplantation; Review; Journal Article

ID*:762 (1984)

von Maltzahn,W.W.; Warriyar,R.G.; Keitzer,W.F.

Experimental measurements of elastic properties of media and adventitia of bovine carotid arteries

J.Biomech. 17(11):839-47


KEYWORDS: media; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't; Muscle, Smooth, Vascular [physiology]; Models, Cardiovascular; In Vitro; Elasticity; Cattle; Carotid Arteries [physiology]; Animals; Journal Article

ID*:763 (2003)

Dame,Michael K.; Yu,Xinwen; Garrido,Rosario; Bobrowski,Walter; McDuffie,J.Eric; Murphy,Hedwig S.; Albassam,Mudher; Varani,James

A stepwise method for the isolation of endothelial cells and smooth muscle cells from individual canine coronary arteries

In Vitro Cell Dev.Biol.Anim. 39(10):402-6


KEYWORDS: smooth muscle cells; Research Support, U.S. Gov't, P.H.S.; Muscle, Smooth, Vascular [cytology]; Microscopy, Phase-Contrast [methods]; Endothelium, Vascular [cytology]; Dogs; Coronary Vessels [cytology]; Coloring Agents; Cell Separation [methods]; Animals; 0 (Coloring Agents); Journal Article

ID*:764 (1993)

Mosora,F.; Harmant,A.; Bernard,C.; Fossion,A.; Pochet,T.; Juchmes,J.; Cescotto,S.

Modelling the arterial wall by finite elements

Arch.Int.Physiol.Biochim.Biophys. 101(3):185-91


KEYWORDS: vessel; Models, Cardiovascular; Hemorheology; Dogs; Blood Pressure [physiology]; Biomechanics; Arteries [physiology]; Aorta, Thoracic [physiology]; Aorta, Abdominal [physiology]; Animals; Journal Article

ID*:765 (2005)

Spiler,Norell M.; Rork,Tyler H.; Merrill,Gary F.

An old drug with a new purpose: cardiovascular actions of acetaminophen (paracetamol)

Curr.Drug.Targets.Cardiovasc.Haematol.Disord. 5(5):419-29


KEYWORDS: cyclooxygenase; prostaglandin; hypoxia; oxygen; vascular; Myocardium [metabolism]; Myocardial Ischemia [drug therapy]; Humans; Cardiotonic Agents [therapeutic use]; Cardiotonic Agents [pharmacology]; Animals; Acetaminophen [therapeutic use]; Acetaminophen [pharmacology]; 103-90-2 (Acetaminophen); 0 (Cardiotonic Agents); Review; Journal Article

ID*:766 (2006)

Bergan,John J.; Schmid-Schönbein,Geert W.; Smith,Philip D.Coleridge; Nicolaides,Andrew N.; Boisseau,Michel R.; Eklof,Bo

Chronic venous disease

N.Engl.J.Med. 355(5):488-98


KEYWORDS: Journal Article

ID*:767 (2006)

Aird,William C.

Endothelium and allotransplantation

Transplantation 82(1 Suppl):S6-8


KEYWORDS: therapy; health; blood vessel; vessel; Endothelium; media; Journal Article

ID*:768 (2006)


Calcium, mitochondria and reperfusion injury: a pore way to die

Biochem.Soc.Trans. 34(Pt 2):232-7


KEYWORDS: knockout; ice; Research Support, Non-U.S. Gov't; Reperfusion Injury [metabolism]; Mitochondrial Membranes [metabolism]; Mitochondria [metabolism]; Cell Membrane Permeability; Calcium [metabolism]; Apoptosis; Animals; 7440-70-2 (Calcium); Review; Journal Article

ID*:769 (2006)

Pacher,Pál; Nivorozhkin,Alex; Szabó,Csaba

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

Pharmacological Reviews 58(1):87-114


KEYWORDS: Allopurinol; ice; vascular; Xanthine Oxidase [chemistry]; Xanthine Oxidase [antagonists & inhibitors]; Superoxides [metabolism]; Research Support, N.I.H., Intramural; Reperfusion Injury [drug therapy]; Inflammatory Bowel Diseases [drug therapy]; Humans; Enzyme Inhibitors [therapeutic use]; Cardiovascular Diseases [drug therapy]; Animals; Allopurinol [therapeutic use]; EC (Xanthine Oxidase); 315-30-0 (Allopurinol); 11062-77-4 (Superoxides); 0 (Enzyme Inhibitors); Review; Journal Article

ID*:770 (2006)

Jones,Steven P.; Bolli,Roberto

The ubiquitous role of nitric oxide in cardioprotection

J.Mol.Cell.Cardiol. 40(1):16-23


KEYWORDS: statins; angiotensin; therapy; iNOS; NOS; NO; nitric oxide; media; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Protective Agents [pharmacology]; Nitrites [metabolism]; Nitric Oxide Synthase Type II [metabolism]; Nitric Oxide Synthase Type II [genetics]; Nitric Oxide Donors [pharmacology]; Nitric Oxide [physiology]; Myocardium [metabolism]; Myocardial Infarction [prevention & control]; Myocardial Infarction [pathology]; Myocardial Infarction [metabolism]; Mitochondria, Heart [metabolism]; Ischemic Preconditioning, Myocardial; Humans; Heart [drug effects]; Animals; EC (Nitric Oxide Synthase Type II); 10102-43-9 (Nitric Oxide); 0 (Protective Agents); 0 (Nitrites); 0 (Nitric Oxide Donors); Review; Journal Article

ID*:771 (2005)

Kandzari,David E.; Dery,Jean-Pierre; Armstrong,Paul W.; Douglas,Deborah A.; Zettler,Marjorie E.; Hidinger,G.Karl-Gunnar; Friesen,Albert D.; Harrington,Robert A.

MC-1 (pyridoxal 5'-phosphate): novel therapeutic applications to reduce ischaemic injury

Expert.Opin.Investig.Drugs. 14(11):1435-42


KEYWORDS: neuroprotective; media; vascular; Research Support, Non-U.S. Gov't; Pyridoxal Phosphate [therapeutic use]; Pyridoxal Phosphate [pharmacology]; Pyridoxal Phosphate [pharmacokinetics]; Pyridoxal Phosphate [adverse effects]; Myocardial Reperfusion Injury [prevention & control]; Myocardial Infarction [drug therapy]; Humans; Clinical Trials; Animals; 54-47-7 (Pyridoxal Phosphate); Review; Journal Article

ID*:772 (2006)


Oxygen-induced reperfusion-injury is caused by ROS: Amelioration is possible by recombinant-DNA antioxidant enzymes and mimics in selected tissues

Med.Hypotheses. 66(2):329-31


KEYWORDS: oxygen; enzyme; Reperfusion Injury [prevention & control]; Reperfusion Injury [chemically induced]; Reactive Oxygen Species; Oxygen [adverse effects]; Molecular Mimicry; DNA, Recombinant; Cytochrome P-450 Enzyme System [genetics]; Cytochrome P-450 Enzyme System [administration & dosage]; Animals; 9035-51-2 (Cytochrome P-450 Enzyme System); 7782-44-7 (Oxygen); 0 (Reactive Oxygen Species); 0 (DNA, Recombinant); Review; Journal Article

ID*:773 (2001)

Cuzzocrea,Salvatore; Riley,Dennis P.; Caputi,Achille P.; Salvemini,Daniela

Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury

Pharmacological Reviews 53(1):135-59


KEYWORDS: sodium channel; therapy; oxygen; media; vascular; enzyme; Shock [drug therapy]; Reperfusion Injury [drug therapy]; Reactive Oxygen Species [metabolism]; Inflammation [drug therapy]; Humans; Free Radicals [metabolism]; DNA Damage; Antioxidants [therapeutic use]; Antioxidants [pharmacology]; Anti-Inflammatory Agents, Non-Steroidal [pharmacology]; Animals; 0 (Reactive Oxygen Species); 0 (Free Radicals); 0 (Antioxidants); 0 (Anti-Inflammatory Agents, Non-Steroidal); Review; Journal Article

ID*:774 (2005)

Motterlini,Roberto; Mann,Brian E.; Foresti,Roberta

Therapeutic applications of carbon monoxide-releasing molecules

Expert.Opin.Investig.Drugs. 14(11):1305-18


KEYWORDS: oxygen; solution; vascular; enzyme; Research Support, Non-U.S. Gov't; Organometallic Compounds [therapeutic use]; Organometallic Compounds [pharmacology]; Myocardial Reperfusion Injury [prevention & control]; Kidney Diseases [drug therapy]; Humans; Heme Oxygenase-1 [physiology]; Carbonates [therapeutic use]; Carbonates [pharmacology]; Carbon Monoxide [metabolism]; Boranes [therapeutic use]; Boranes [pharmacology]; Blood Pressure [drug effects]; Anti-Inflammatory Agents [pharmacology]; Animals; EC (Heme Oxygenase-1); 630-08-0 (Carbon Monoxide); 0 (tricarbonyldichlororuthenium (II) dimer); 0 (tricarbonylchloro(glycinato)ruthenium(II)); 0 (sodium boranocarbonate); 0 (Organometallic Compounds); 0 (Carbonates); 0 (Boranes); 0 (Anti-Inflammatory Agents); Review; Journal Article

ID*:775 (2006)

Khalil,Alizan A.; Aziz,Farah A.; Hall,John C.

Reperfusion injury

Plast.Reconstr.Surg. 117(3):1024-33


KEYWORDS: Reperfusion; oxygen; vascular; Surgical Flaps [blood supply]; Replantation; Reperfusion Injury [therapy]; Reperfusion Injury [physiopathology]; Reactive Oxygen Species; Leukocytes [physiology]; Ischemic Preconditioning; Hypothermia, Induced; Humans; Free Radical Scavengers [therapeutic use]; Finger Injuries [surgery]; Fibrinolytic Agents [therapeutic use]; Extremities [surgery]; Extremities [injuries]; Endothelium, Vascular [injuries]; Animals; 0 (Reactive Oxygen Species); 0 (Free Radical Scavengers); 0 (Fibrinolytic Agents); Review; Journal Article

ID*:776 (2005)

Kozhura,Vyacheslav Leontjevich; Basarab,Dmitriy Alexeevich; Timkina,Marina Innokentievna; Golubev,Arkadiy Mikhailivich; Reshetnyak,Vasiliy Ivanovich; Moroz,Viktor Vasiljevich

Reperfusion injury after critical intestinal ischemia and its correction with perfluorochemical emulsion "perftoran"

World J.Gastroenterol. 11(45):7084-90


KEYWORDS: Reperfusion; blood pressure; ice; vascular; Reperfusion Injury [therapy]; Reperfusion Injury [physiopathology]; Reperfusion Injury [pathology]; Rats; Male; Intestines [injuries]; Intestines [blood supply]; Intestinal Mucosa [pathology]; Intestinal Mucosa [injuries]; Fluorocarbons [administration & dosage]; Emulsions; Blood Substitutes [administration & dosage]; Animals; 99752-82-6 (perftoran); 0 (Fluorocarbons); 0 (Emulsions); 0 (Blood Substitutes); Journal Article

ID*:777 (2002)


An introduction to biofluid mechanics--basic models and applications

J.Biomech. 35(4):415-35


KEYWORDS: mechanics; diagnostics; Viscosity; patch; ice; vessel; veins; vascular; Research Support, Non-U.S. Gov't; Models, Cardiovascular; Humans; Hemorheology [methods]; Hemodynamic Processes [physiology]; Body Fluids [physiology]; Biomechanics; Animals; Lectures

ID*:778 (1988)

Crompton,M.; Ellinger,H.; Costi,A.

Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress

Biochem.J. 255(1):357-60


KEYWORDS: Sucrose; tert-Butylhydroperoxide; Sucrose [pharmacokinetics]; Research Support, Non-U.S. Gov't; Rats, Inbred Strains; Rats; Phosphates [pharmacology]; Peroxides [pharmacology]; Oxidation-Reduction; Mitochondria, Heart [metabolism]; Mitochondria, Heart [drug effects]; Membrane Potentials [drug effects]; Intracellular Membranes [metabolism]; Intracellular Membranes [drug effects]; Female; Cyclosporins [pharmacology]; Cell Membrane Permeability [drug effects]; Calcium [pharmacology]; Animals; 75-91-2 (tert-Butylhydroperoxide); 7440-70-2 (Calcium); 57-50-1 (Sucrose); 0 (Phosphates); 0 (Peroxides); 0 (Cyclosporins); Journal Article

ID*:779 (1999)

Kerr,P.M.; Suleiman,M.S.; Halestrap,A.P.

Reversal of permeability transition during recovery of hearts from ischemia and its enhancement by pyruvate

Am.J.Physiol. 276(2 Pt 2):H496-502


KEYWORDS: pH; Rats, Wistar; Rats; Pyruvic Acid [pharmacology]; Osmolar Concentration; Myocardium [metabolism]; Myocardial Reperfusion Injury [physiopathology]; Myocardial Ischemia [physiopathology]; Myocardial Contraction [drug effects]; Mitochondria, Heart [physiology]; Male; Lactic Acid [metabolism]; In Vitro; Hydrogen-Ion Concentration; Deoxyglucose [pharmacokinetics]; Capillary Permeability [physiology]; Capillary Permeability [drug effects]; Animals; Adenine Nucleotides [metabolism]; 50-21-5 (Lactic Acid); 154-17-6 (Deoxyglucose); 127-17-3 (Pyruvic Acid); 0 (Adenine Nucleotides); Journal Article

ID*:780 (2003)

Aird,William C.

Endothelial cell heterogeneity

Crit.Care.Med. 31(4 Suppl):S221-30


KEYWORDS: health; blood vessel; vessel; Respiratory Mucosa [physiology]; Respiratory Mucosa [blood supply]; Respiratory Distress Syndrome, Adult [physiopathology]; Research Support, U.S. Gov't, P.H.S.; Phenotype; Humans; Endothelium, Vascular [physiology]; Endothelium, Vascular [metabolism]; Animals; Review; Journal Article

ID*:781 (2006)


Endothelial NO synthase as a source of NO and superoxide

European Journal of Clinical Pharmacology 62 Suppl 13:5-12


KEYWORDS: heme; angiotensin; oxygen; NOS; NO; nitric oxide; eNOS; vascular; enzyme; Journal Article

ID*:782 (1995)

Morris,P.E.; Wheeler,A.P.; Meyrick,B.O.; Bernard,G.R.

Escherichia coli endotoxin-mediated endothelial injury is modulated by glutathione ethyl ester

J.Infect.Dis. 172(4):1119-22


KEYWORDS: Escherichia coli; prostaglandin; Glutathione; media; prostacyclin; Toxicity Tests; Research Support, U.S. Gov't, P.H.S.; Pulmonary Artery [cytology]; L-Lactate Dehydrogenase [analysis]; Glutathione [pharmacology]; Glutathione [analogs & derivatives]; Endotoxins [toxicity]; Endothelium, Vascular [pathology]; Endothelium, Vascular [drug effects]; Endothelium, Vascular [cytology]; Dose-Response Relationship, Drug; Dinoprostone [analysis]; Cell Line; Cattle; Animals; EC (L-Lactate Dehydrogenase); 70-18-8 (Glutathione); 67924-63-4 (endotoxin, Escherichia coli); 363-24-6 (Dinoprostone); 24425-52-3 (S-ethyl glutathione); 0 (Endotoxins); Journal Article

ID*:783 (2002)

Clarke,Samantha J.; McStay,Gavin P.; Halestrap,Andrew P.

Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A

J.Biol.Chem. 277(38):34793-9


KEYWORDS: Spiro Compounds [pharmacology]; Research Support, Non-U.S. Gov't; Rats; Myocardial Reperfusion Injury [prevention & control]; Mitochondria, Heart [drug effects]; Lactones [pharmacology]; In Vitro; Cyclosporine [metabolism]; Cyclophilins [metabolism]; Cell Membrane Permeability [drug effects]; Binding Sites; Animals; EC (cyclophilin D); EC 5.2.1.- (Cyclophilins); 59865-13-3 (Cyclosporine); 0 (sanglifehrin A); 0 (Spiro Compounds); 0 (Lactones); Journal Article

ID*:784 (2006)

Rork,Tyler H.; Hadzimichalis,Norell M.; Kappil,Maya A.; Merrill,Gary F.

Acetaminophen attenuates peroxynitrite-activated matrix metalloproteinase-2-mediated troponin I cleavage in the isolated guinea pig myocardium

J.Mol.Cell.Cardiol. 40(4):553-61


KEYWORDS: MMP; media; Troponin I [metabolism]; Research Support, Non-U.S. Gov't; Peroxynitrous Acid [pharmacology]; Perfusion [methods]; Myocytes, Cardiac [metabolism]; Myocytes, Cardiac [cytology]; Myocardium [metabolism]; Myocardium [cytology]; Male; Guinea Pigs; Gelatinase A [metabolism]; Animals; Analgesics, Non-Narcotic [pharmacology]; Acetaminophen [pharmacology]; EC (Gelatinase A); 14691-52-2 (Peroxynitrous Acid); 103-90-2 (Acetaminophen); 0 (Troponin I); 0 (Analgesics, Non-Narcotic); Journal Article